Macquarie Group LTD Uni Qure N.V. Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Uni Qure N.V. stock. As of the latest transaction made, Macquarie Group LTD holds 706,166 shares of QURE stock, worth $3.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

706,166

Previous 706,166 -0.0%

Holding current value

$3.59 Million

Previous $3.67 Million 13.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	SELL	$18.12 - $27.32 $6,233 - $9,398	-344 Reduced 0.05%	706,166 $16 Million
Q3 2022 Nov 14, 2022	SELL	$16.98 - $25.54 $10,714 - $16,115	-631 Reduced 0.09%	706,510 $13.3 Million
Q1 2021 May 14, 2021	SELL	$29.24 - $42.03 $8,742 - $12,566	-299 Reduced 0.04%	707,141 $23.8 Million
Q2 2020 Aug 11, 2020	BUY	$45.06 - $67.74 $442,624 - $665,410	9,823 Added 1.41%	707,440 $31.9 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $60,039 - $120,660	1,617 Added 0.23%	697,617 $50 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $118,080 - $230,400	3,000 Added 0.43%	696,000 $27.4 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $685,880 - $1.07 Million	13,000 Added 1.91%	693,000 $54.2 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $2.27 Million - $5.68 Million	83,000 Added 13.9%	680,000 $40.6 Million
Q3 2018 Nov 15, 2018	SELL	$29.75 - $43.08 $56,525 - $81,852	-1,900 Reduced 0.32%	597,000 $21.7 Million
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $195,444 - $355,466	8,900 Added 1.51%	598,900 $22.6 Million
Q1 2018 May 11, 2018	BUY	$17.1 - $26.61 $990,962 - $1.54 Million	57,951 Added 10.89%	590,000 $13.9 Million
Q4 2017 Feb 15, 2018	BUY	$9.47 - $19.59 $4.38 Million - $9.05 Million	462,049 Added 660.07%	532,049 $10.4 Million
Q3 2017 Nov 08, 2017	BUY	$7.7 - $9.6 $539,000 - $672,000	70,000	70,000 $672,000

Others Institutions Holding QURE

# of Institutions

141

Shares Held

33.7M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $237M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Uni Qure N.V. Transaction History